Tag: SB-01

Spine BioPharma announces first patient treated in US Phase 3 clinical...

Spine BioPharma recently announced the first patient treated in a Phase 3 clinical study of SB-01. This, according to the company, is the first...

Spine BioPharma completes US$13m Series B financing round

Spine BioPharma, a biopharmaceutical company that aims to develop non-opiate, non-surgical therapies for the treatment of pain and disability from chronic low back pain...